Galapagos NV
GLPG
#4563
Rank
C$2.91 B
Marketcap
C$43.64
Share price
-0.57%
Change (1 day)
15.49%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$1.72 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are C$1.72 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$1.84 B-19.22%
2023-12-31C$2.28 B-28.76%
2022-12-31C$3.21 B-12.66%
2021-12-31C$3.68 B-23%
2020-12-31C$4.77 B2.31%
2019-12-31C$4.67 B1230.88%
2018-12-31C$0.35 B-15.17%
2017-12-31C$0.41 B-9.83%
2016-12-31C$0.45 B290.3%
2015-12-31C$0.11 B29.49%
2014-12-31C$90.79 M-48.63%
2013-12-31C$0.17 B14.97%
2012-12-31C$0.15 B172.7%
2011-12-31C$56.37 M-6.71%
2010-12-31C$60.43 M15.1%
2009-12-31C$52.5 M-10.46%
2008-12-31C$58.64 M-19.64%
2007-12-31C$72.97 M-18.25%
2006-12-31C$89.26 M216.85%
2005-12-31C$28.17 M229.61%
2004-12-31C$8.54 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
C$94.61 B 5,379.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$156.85 B 8,984.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$91.21 B 5,182.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
C$188.57 B 10,821.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
C$0.16 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$45.47 B 2,533.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$45.03 B 2,508.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$84.66 B 4,803.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$107.25 B 6,112.06%๐Ÿ‡บ๐Ÿ‡ธ USA